Directory
>
Robert Meyer
Robert Meyer
Retired | Chimerix, Inc.
Nellysford, Virginia, United States
Robert Meyer
Summary
Robert Meyer is a seasoned professional in the life sciences sector with extensive experience in regulatory strategy and drug development. He has held leadership positions at major organizations, including Merck and the FDA, where he contributed significantly to global regulatory policy and product safety. Currently, he serves as Principal at Eliquent Life Sciences, focusing on drug and biological products. His academic background in medicine, combined with a fellowship in pulmonary and critical care, underpins his clinical expertise. Robert is passionate about advancing human health through effective drug approval strategies and has a keen interest in biomarkers and translational medicine. He has also served on the boards of various organizations, showcasing his commitment to governance and strategic oversight. Robert's diverse experience, spanning consulting, research, and regulatory affairs, positions him as a key player in the biopharmaceutical landscape.
Robert Meyer
Work Experience
Retired at
None
October 2024 - Present
Non-Executive Director (Board member) at
Chimerix, Inc.
March 2018 - Present
Principal, Drug and Biological Products at
ELIQUENT LIFE SCIENCES LIMITED
January 2024 - October 2024
Principal, Drug and Biological Products at
Greenleaf Health, Inc.
January 2018 - October 2024
Non-Executive Director at
Translate Bio
January 2019 - September 2021
Member Board of Trustees at
US Pharmacopeia
July 2015 - June 2020
Member Board of Directors at
Correvio Pharma
September 2015 - November 2019
Director, VCTRS at
Rector & Visitors of The University of Virginia
February 2013 - December 2017
VP, Global Regulatory Strategy, Policy and Safety at
Merck
November 2009 - January 2013
Chair, RACC at
Pharmaceutical Research & Mfg
January 2012 - January 2013
Vice President, Global Regulatory Strategic Development at
Merck
February 2008 - November 2009
Director, Office of Drug Evaluation II at
FDA
January 1994 - January 2007
Member at
Mtocatoc
January 1998 - January 2007
Director, ODE2 at
FDA
January 2002 - January 2007
Assistant Professor, Co-Medical Director of Lung Transplantation at
Oregone Health And Sciences University
January 1991 - January 1994
Robert Meyer
Education
University of Vermont College of Medicine, Fellowship, Pulmonary And Critical Care Medicine
January 1988 - January 1991
The University of Connecticut School of Medicine, Residency/Chief Residency
January 1984 - January 1988
The University of Connecticut School of Medicine, Md
January 1980 - January 1984
Lehigh University, Bachelor Of Arts - Ba
January 1976 - January 1980
Pomfret School, Secondary School Graduate
January 1972 - January 1976
Thompson Memorial School
January 1970 - January 1972
Frequently Asked Questions about Robert Meyer
What is Robert Meyer email address?
Robert Meyer's primary email address is *********@greenleafhealth.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Robert Meyer work for?
Robert Meyer is a Retired at Chimerix, Inc., a company specializing in Commercial physical research.
Where Robert Meyer graduated from?
Robert Meyer holds a degree in Pulmonary Disease Residency Program from University of Vermont College of Medicine.
How can I directly contact Robert Meyer?
To contact Robert Meyer directly, you can use the email address *********@greenleafhealth.com. Complete contact information is available upon registration with Muraena.
Who is Robert Meyer?
Robert Meyer is a seasoned professional in the life sciences sector with extensive experience in regulatory strategy and drug development. He has held leadership positions at major organizations, including Merck and the FDA, where he contributed significantly to global regulatory policy and product safety. Currently, he serves as Principal at Eliquent Life Sciences, focusing on drug and biological products. His academic background in medicine, combined with a fellowship in pulmonary and critical care, underpins his clinical expertise. Robert is passionate about advancing human health through effective drug approval strategies and has a keen interest in biomarkers and translational medicine. He has also served on the boards of various organizations, showcasing his commitment to governance and strategic oversight. Robert's diverse experience, spanning consulting, research, and regulatory affairs, positions him as a key player in the biopharmaceutical landscape.
Robert`s contact details
*********@greenleafhealth.com
************@merck.com
************@fda.gov
******@correvio.com
******@cardiome.com
******@translate.bio
Colleagues
Executive Director of Quality Assurance
Vice President, Biostatistics
Member Board of Directors
Chief Scientific Officer
Executive Director, Human Resources
Vice President Regulatory Affairs
Executive Director, Nonclinical Development Strategy and Translational Medicine
VP Clinical Pharmacology/Translational Medicine